| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Allogene Therapeutics, Inc. (ALLO) has 9 insiders with recent SEC Form 4 filings, including 6 buys and 1 sell. ALLO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 1.28M | $2.97M | - | |
| VP | 217.7K | $507.3K | - | |
| Dir | 144.4K | $336.5K | - | |
| Dir | 95.4K | $222.3K | - | |
| Dir | 95.4K | $222.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2019 | Tpg Group Holdings (sbs) Advisors, Inc.86 | 10% Owner | Sell | 1,918,755 | $29.38 | $56,373,021.90 | -8.3% | |
| Oct 15, 2018 | Belldegrun Arie | Director, 10% Owner | Buy | 35,000 | $18.00 | $630,000.00 | New | |
| Oct 15, 2018 | Pfizer Inc | 10% Owner | Buy | 55,556 | $18.00 | $1,000,008.00 | +0.3% | |
| Oct 15, 2018 | Chang David D56 | President And CEO | Buy | 40,000 | $18.00 | $720,000.00 | +2.0% | |
| Oct 15, 2018 | Witte Owen N.76 | Director | Buy | 15,000 | $18.00 | $270,000.00 | +8.2% | |
| Oct 15, 2018 | Humer Franz B | Director | Buy | 30,000 | $18.00 | $540,000.00 | New | |
| Oct 15, 2018 | Tpg Group Holdings (sbs) Advisors, Inc.86 | 10% Owner | Buy | 675,000 | $18.00 | $12,150,000.00 | +3.0% |